About
- About Svar
- Career
- Distributors
- Events
- Complement Excellence Award
- News
Products
- All Products
- Complement Assays
- Cell-Based Assays
- Gene Therapy Assays
- CCP Assays
Services
- CRO Services
- Diagnostic Services
- Custom Cell Development
- Cell Manufacturing
Applications
- Potency Testing
- Safety Assessment
- Biomarker Profiling
- Clinical Assessment
- Bioanalysis
- Regulatory Testing
- Complement System Evaluation
- Gene & Cell Therapy Evaluation
- Biosimilar & Biobetter Assessment
Knowledge
- Knowledge Hub
- Scientific Publications
- Videos & Webinars
- Product Documentation
About
About Svar
Career
Distributors
Events
Complement Excellence Award
News
Products
View our comprehensive portfolio of products for drug development and patient diagnosis and monitoring
All Products
Our products are trusted worldwide in research, clinical, and commercial laboratory settings.
Complement Assays
Functional and biomarker assays for the exploration of every angle of the complement system
Cell-Based Assays
Our cell-based bioassays are based on iLite® technology – a cleverly designed cell-based assay system with reporter gene readouts
Gene Therapy Assays
AAV Neutralizing Antibody (NAb), Total Antibody (TAb), and Complement Activation assays designed to provide a comprehensive view of vector immunogenicity
CCP Assays
Solutions for detecting and semi-quantitating IgG antibodies against CCP
Services
CRO Services
Our extensive CRO Services offer bioanalysis, biomarker discovery, and GMP QC testing.
Diagnostic Services
With over 30 years of experience in autoimmune diagnostics, our ISO15189-certified specialist laboratory can help you reach the correct diagnosis. We also provide testing services and support for therapeutic drug monitoring.
Custom Cell Development
Let us develop a custom iLite® cell line tailored to your needs.
Cell Manufacturing
Our cell services are highly reliable and innovative, tailored to your manufacturing needs
Applications
Potency Testing
Safety Assessment
Biomarker Profiling
Clinical Assessment
Bioanalysis
Regulatory Testing
Complement System Evaluation
Gene & Cell Therapy Evaluation
Biosimilar & Biobetter Assessment
Knowledge
Knowledge Hub
Scientific Publications
Videos & Webinars
Product Documentation
- BM5028 iLite® CD20 (+) Svar Luc Assay Ready Cells
- BM5001 iLite® ADCC Effector FcγRIIIa (V)
- BM5004 iLite® ADCP Effector FcγRIIa
- BM4073 iLite® C3a Assay Ready Cells
- BM4075 iLite® C5a Assay Ready Cells
- BM3044 iLite® TNF-alpha Assay Ready Cells
- BM4052 iLite® RANKL Assay Ready Cells
- BM4044 iLite® TNF-alpha Xcel Assay Ready Cells
- BM4049 iLite® Type I IFN FAST Assay Ready Cells
- BM3071 iLite® FGF-21 Assay Ready Cells
- BM4055 iLite® G-CSF Assay Ready Cells
- BM4050 iLite® GM-CSF Assay Ready Cells
- BM4021 iLite® VEGF Assay Ready Cells
- BM4080 iLite® hCG Assay Ready Cells
- BM3060 iLite® Insulin Assay Ready Cells
- BM4023 iLite® IL-23 Assay Ready Cells
- BM4012 iLite® IL-12 Assay Ready Cells
- BM4002 iLite® IL-2 Assay Ready Cells
- BM4061 iLite® IL-6 Assay Ready Cells
- BM4025 iLite® TLR4 Assay Ready Cells
- BM6069 iLite® TLR9 Assay Ready Cells
- BM6100 iLite® AAV Responsive Reporter Assay Ready Cells
- BM6002 iLite® AAV2 Packaging Assay Ready Cells
- BM6005 iLite® AAV5 Packaging Assay Ready Cells
- BM6006 iLite® AAV6 Packaging Assay Ready Cells
- BM6008 iLite® AAV8 Packaging Assay Ready Cells
- BM6009 iLite® AAV9 Packaging Assay Ready Cells
- BM5005 iLite® CD3 Effector
- BM5025 iLite® CD19 (+) Target
- BM5026 iLite® CD19 (-) Target
- BM5010 iLite® CD20 (+) Target
- BM5015 iLite® CD20 (-) Target
- BM5035 iLite® EGFR (+) Target
- BM5036 iLite® EGFR (-) Target
- BM5011 iLite® HER2 (+) Target
- BM5016 iLite® HER2 (-) Target
- BM5013 iLite® mTNF-alpha (+) Target
- BM5014 iLite® mTNF-alpha (-) Target
- BM5017 iLite® mVEGF (+) Target
- BM5018 iLite® mVEGF (-) Target
- COMPL C4d RUO Complement C4d
- COMPL FPQ RUO Complement Factor P Quantitative Assay
- COMPL TCC RUO Complement TCC
- COMPL FPF RUO Complement Factor P Functional Assay
- COMPLAP330 WIESLAB® Complement Alternative Pathway (IVD)
- COMPLAP330RUO WIESLAB® Complement Alternative Pathway (RUO)
- COMPLCP310 WIESLAB® Complement Classical Pathway (IVD)
- COMPLCP310RUO WIESLAB® Complement Classical Pathway (RUO)
- COMPLMP320 WIESLAB® Complement MBL Pathway (IVD)
- COMPLMP320RUO WIESLAB® Complement MBL Pathway (RUO)
- COMPL300 WIESLAB® Complement Screen (IVD)
- COMPL300RUO WIESLAB® Complement Screen (RUO)
- RA-96 PLUS IMMUNOSCAN CCPlus® (IVD)
- RA-96 PLUS RUO IMMUNOSCAN CCPlus® (RUO)
- 008 C-/P-ANCA
- 017 Cardiolipin Antibodies (IgA)
- 018 Autoimmune Liver Disease Screen
- 020 ANA (HEp-2)
- 023 dsDNA Antibodies (IgG)
- 024 ANA Specificities
- 025 Sm Antibodies
- 027 SSA/Ro60 Antibodies
- 028 SSB/La Antibodies
- 031 Ribosomal P-Protein (Ribo-P) Antibodies
- 032 SSA/Ro52 Antibodies
- 047 FGFR3 Antibodies (IgG)
- 071 Endomysial Antibodies (IgA)
- 074 Transglutaminase Antibodies (IgA)
- 079 Acetylcholine Receptor Antibodies
- 082 Smooth Muscle Antibodies (SMA)
- 084 Mitochondrial Antibodies (AMA)
- 085 Striational Antibodies
- 086 Adrenal Cortex Antibodies
- 087 Parietal Cell Antibodies
- 089 GAD Antibodies
- 090 Islet Cell Antibodies
- 093 MAG Antibodies
- 095 HSP-70 Antibodies
- 098 Histone Antibodies
- 100 GBM Antibodies (IgG4)
- 110 Insulin Antibodies
- 111 IA-2 Antibodies
- 113 ZnT8 Antibodies
- 117 mGluR1 Antibodies (IgG)
- 118 mGluR5 Antibodies (IgG)
- 119 Neurofilament Heavy Chain (pNfH)
- 140 THSD7A Antibodies (IgG)
- 141 cN-1A (Mup44) Antibodies (IgG)
- 146 Beta-2-Glycoprotein Antibodies (IgA)
- 205 Envoplakin Antibodies (IgG)
- 220 Hu (ANNA-1) Antibodies (IgG)
- 240 Streptolysin O Antibodies
- 247 PLA2R Antibodies ELISA (IgG)
- 280 Collagen Type VII IgG Antibodies (IgG)
- 291 HLA-DQB1*06:02 (Narcolepsy)
- 355 Sulfatide Antibodies (IgM)
- 450 RNA Polymerase Antibodies
- 485 HMGCR Antibodies
- 500 Glomerulonephritis – Extended Analysis
- 501 ANCA Vasculitis/Anti-GBM Disease (Goodpasture Syndrome)
- 510 Antiphospholipid Syndrome (APS)
- 511 Systemic Lupus Erythematosus (SLE)/Sjogren's Syndrome
- 515 Autoimmune Liver Disease
- 516 Cardiolipin Antibodies (IgG, IgM)
- 517 Beta-2-Glycoprotein 1 Antibodies (IgG, IgM)
- 522 Systemic Sclerosis/Scleroderma
- 527 Systemic Sclerosis/Scleroderma – Extended Analysis
- 530 Sudden Deafness
- 531 Diabetes Mellitus Type 1
- 534 Guillain-Barré Syndrome/AIDP
- 620 Autoimmune Nodopathy/CIDP – Screen IgG
- 533 Autoimmune Nodopathy/CIDP – Extended Analysis with Reflex (IgG1-4)
- 541 Drug Induced Lupus
- 543 Myasthenia Gravis
- 548 Myositis/ Interstitial Lung Disease (ILD) Screen
- 550 Bullous Dermatosis
- 555 Inflammatory Myopathies (Myositis)/Interstitial Lung Disease (ILD)
- 563 Lambert Eatons Myastena Syndrome (LEMS)
- 566 CNS Tissue Damage Biomarker
- 568 Stiff Person Syndrome
- 569 Paraneoplastic Retinopathy Syndrome (MAR/CAR)
- 571 Hereditary Angioedema (HAE)
- 572 Complement Deficiency
- 584 Primary Membranous Nephropathy (PMN)
- 575 Autoimmune Pancreatitis Type 2 (AIP2)
- 600 Fibrillarin Antibodies
- 546 Ganglioside Antibodies (IgG, IgM)
- 710 PM/Scl (100kD) Antibodies
- 720 Th/To Antibodies
- 730 Amphiphysin Antibodies (IgG)
- 736 Recoverin Antibodies (IgG)
- 737 SOX1 Antibodies (IgG)
- 740 Yo (Purkinje cell) Antibodies (IgG)
- 742 Zic4 Antibodies (IgG)
- 750 Ri (Nova 1/ ANNA-2) Antibodies (IgG)
- 760 Tr Antibodies (IgG)
- 761 PCA-2 Antibodies
- 772 AMPA Receptor 1/2 Antibodies (IgG)
- 780 21-Hydroxylase Antibodies
- 790 Ma (Ma-2/Ta) Antibodies (IgG)
- 831 VGKC Antibodies (IgG)
- 833 LGI-1 Antibodies (IgG)
- 835 CASPR2 Antibodies (IgG)
- 837 Alpha-Enolase Antibodies
- 838 Glycine Receptor Antibodies (IgG)
- 839 Ryanodin Receptor 1 (RyR1) Antibodies
- 845 VGCC Antibodies
- 850 Carbonic Anhydrase II Antibodies
- 851 DPPX Antibodies (IgG)
- 852 IgLON5 Antibodies (IgG)
- 854 CARP VIII Antibodies (IgG)
- 855 HOMER3 Antibodies (IgG)
- 856 ITPR1 Antibodies (IgG)
- 859 Lactoferrin (DNA-Bound) Antibodies (IgG)
- 870 CV2/CRMP5 Antibodies (IgG)
- 874 ANNA-3 Antibodies
- 875 NMDA Receptor Antibodies (IgG)
- 877 GABA B Receptor Antibodies (IgG)
- 880 Aquaporin 4 (AQP4) Antibodies (IgG)
- 884 MOG Antibodies (IgG)
- 890 C1q Antibodies
- 920 C1q
- 925 C1 INH Level
- 930 C3d
- 958 Lrp4 Antibodies
- 959 Ganglionic AChR Antibodies
- 960 MuSK Antibodies (IgG)
- 965 Titin Antibodies (IgG)
- 970 Trib2 Antibodies
- 988 CXCL13
- 989 Orexin (Hypokretin-1)
- 990 Tau
- 991 pTau
- 992 Beta-Amyloid 42
- 994 Neurofilament Light (NfL)
- 260, 282 Bullous Pemphigoid (BP180/BP230) Antibodies (IgG)
- 403 Phosphatidylserine Antibodies (IgGAM)
- 404 Phosphatidylserine Antibodies (IgA)
- 405 Phosphatidylserine Antibodies (IgG)
- 406 Phosphatidylserine Antibodies (IgM)
- 460, 470 Desmoglein 1 and 3 Antibodies (IgG)
- 900 C3
- 910 C4
- 565 Neuromyelitis Optica Spectrum Disorder (NMOSD)/MOGAD
- 549 Neuromyelitis Optica Spectrum Disorder – Tissue Damage Biomarkers
- 536 BPI-ANCA (IgG, IgA)
- 573 Complement Function
- 931 Properdin
- 520 Systemic Inflammatory Disease
- 567 Alzheimer's Disease Biomarkers
- 579 Antiphospholipid Syndrome (APS) – Extended Analysis
- 570 Complement Activation
- 836 CASPR1 Antibodies (IgG)
- 997 Beta Amyloid Ratio 42/40
- 926 C1 INH Function
- 996 GFAp Antibodies (IgG)
- 581 Multiple Sclerosis (MS)
- 580 Amyotrophic Lateral Sclerosis (ALS) Biomarkers
- 585 Autoimmune Epilepsy
- 586 Autoimmune Epilepsy – Extended Analysis
- 872 Neurexin-3 Alpha Antibodies (IgG)
- 876 GABA A Receptor Antibodies (IgG)
- 080 Agrin Antibodies
- 052 Dopamin-2 Receptor Antibodies (IgG)
- 871 Neurochondrin Antibodies (IgG)
- 804 TS-HDS Antibodies (IgM)
- 986 Neurogranin
- 535 Small Fiber Neuropathy (SFN)
- 195 Autoimmune Encephalitis
- 199 Paraneoplastic Syndrome (IIF and Immunoblot)
- 560 Autoimmune Encephalitis, Paraneoplastic Syndrome & Cerebellar Ataxia
- 562 Neuronal Antibodies – Extended Analysis
- 587 Pediatric Autoimmune Encephalitis
- 574 Ophelia’s Syndrome (Paraneoplastic Cerebellar Ataxia or Limbic Encephalitis)
- 588 Pediatric Autoimmune Encephalitis – Extended Analysis
- 987 pTau-181
- 805 Plexin D1 Antibodies (IgG)
- 539 Small Fiber Neuropathy (SFN) – Extended Analysis
- 878 Sez6L2 Antibodies (IgG)
- 011 PR3-ANCA (IgG)
- 015 MPO-ANCA (IgG)
- 002 GBM Antibodies (IgG)
- 245 PLA2R Antibodies IIF (IgG)
- 294 ApoE4 Genotyping
- 868 KCNA2 antibodies (IgG)
- 557 Alzheimer's Disease Biomarkers – Extended Analysis
- 124 Infliximab
- 126 Adalimumab
- 128 Etanercept
- 130 Golimumab
- 132 Certolizumab
- 138 Vedolizumab
- 605 Ustekinumab
- 136 Natalizumab
- 613 Eculizumab
- 603 Rituximab
- 615 Abatacept
- 607 Tocilizumab
- 105 Erythropoietin
- 957 KLHL11 Antibodies (IgG)
- 558 Narcolepsy
- 540 Autoimmune Nodopathy/CIDP – Subclass Screen (IgG1-4)
- 883 Aquaporin 4 (AQP4) Antibodies (IgG) – Live CBA
- 885 MOG Antibodies (IgG) – Live CBA
- 561 Neuromyelitis Optica Spectrum Disorder (NMOSD)/MOGAD – Live CBA
- 985 Glial Fibrillary Acidic Protein (GFAP)
- 200 Neuronal Antibody Screen – Tissue-Based Assay (TBA)
- 502 Autoantibodies in Dementia-Like Conditions
- 506 Inflammatory Neuropathy Screen– Extended Analysis
- iLite
- Complement
- Calpro
